05154oam 2200769I 450 991079032640332120230124190518.01-136-59624-01-283-52094-X97866138333960-203-33256-31-136-59625-910.4324/9780203332566 (CKB)2670000000230887(EBL)987918(OCoLC)804661690(SSID)ssj0000696563(PQKBManifestationID)12328966(PQKBTitleCode)TC0000696563(PQKBWorkID)10682451(PQKB)11063344(MiAaPQ)EBC987918(Au-PeEL)EBL987918(CaPaEBR)ebr10589152(CaONFJC)MIL383339(OCoLC)804038669(OCoLC)758983071(FINmELB)ELB139092(EXLCZ)99267000000023088720180706d2012 uy 0engur|n|---|||||txtccrRegenerating bodies tissue and cell therapies in the twenty-first century /Julie KentAbingdon, Oxon ;New York, N.Y. :Routledge,2012.1 online resource (241 p.)Genetics and societyGenetics and societyDescription based upon print version of record.1-138-02011-7 0-415-68881-7 Includes bibliographical references (p. [191]-208) and index.Cover; Regenerating Bodies; Copyright; Contents; Preface; Acknowledgements; 1. Commodifying tissues and cells: The new tissue economies; Introduction; Emerging bioeconomies; Sourcing tissues for health technologies; Engineering tissues; Stem cells; The skin business; Engineering skin; Conclusion; 2. Regenerative medicine: a paradigm shift?; Introduction; Continuities with the past: culturing cells; Governing science with new institutions: the UK Stem Cell Bank; Boundary making; Distributed networks, commercialization and therapeutic use of stem cellsInnovation, transplantation medicine and stem cell scienceInnovation in neuroscience using fetal tissue; Conclusion; 3. Regulation and governance of tissue- and cell-based therapies in Europe: Ethical controversy and the politics of risk; Introduction; Ethical controversy and the principle of subsidiarity; Banking communities; Industry and the regulatory state: regulating the market in human-tissue products; Conclusion; 4. A 'strict but permissive approach': A case study of UK regulation of human-tissue and cell therapies; Introduction; Progressive science and UK science policyThe HFEA model, 1990-2008A national scandal: from professional self-regulation to a new regulatory order; Using human tissues in research; Tissue banking: therapeutic use of human tissue and cells; Regulating hybridity and boundary objects; Conclusion; 5. 'Football fields of skin': a masculinist dream?; Introduction; Gender, science and technology; Defining clinical (social) need; Cartilage repair and regeneration; Women's labour: gendering the bioeconomy; The fetal-tissue economy; Conclusion; 6. Remaking the self; Introduction; Technologies of the body; Multiplications; Self and otherBeing human, donating tissue for research and therapiesPlastic bodies; Culturing cells and regulating the self; Beyond limits: materiality and subjectivity; Towards a feminist bioethics of the body; Conclusion; 7. Life, death and immortality; Introduction; Women and embryos: informed consent; Abortion, fetal death, corpses and organ donation: the right to choose; From transplantation medicine to regenerative medicine: innovation stories; Feminist (embodied) futures?; Conclusion; Appendix; Notes; Bibliography; IndexThis exciting book examines how human tissues and cells are being exchanged, commodified and commercialized by new health technologies. Through a discussion of emergent global 'tissue economies' the author explores the social dynamics of innovation in the fields of tissue engineering and stem cell science. The book explores how regenerative medicine configures and conceptualizes bodies and argues that the development of regenerative medicine is a feminist issue. In Regenerating Bodies, Kent critically examines the transformative potential of regenerative medicine andGenetics and society (Series)Regenerative medicineMoral and ethical aspectsStem cellsResearchMoral and ethical aspectsMedical technologyForecastingFeminism and scienceRegenerative medicineMoral and ethical aspects.Stem cellsResearchMoral and ethical aspects.Medical technologyForecasting.Feminism and science.174.2/8Kent Julie1957-,1465060MiAaPQMiAaPQMiAaPQBOOK9910790326403321Regenerating bodies3674902UNINA